|Other Accession||Q902F9, O42043, O71037, P61566, P61570, Q9HDB8, Q69384, P61567, Q902F8, Q9UKH3, P63135|
|Other Names||Endogenous retrovirus group K member 21 Env polyprotein, EnvK1 protein, Envelope polyprotein, HERV-K_12q14.1 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERVK-21|
|Target/Specificity||The synthetic peptide sequence is selected from aa 291-302 of HUMAN ERVK-21|
|Format||Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties.|
|Cellular Location||[Transmembrane protein]: Cell membrane; Single-pass type I membrane protein [Endogenous retrovirus group K member 21 Env polyprotein]: Virion|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its original fusogenic properties.
Scherer S.E.,et al.Nature 440:346-351(2006).
de Parseval N.,et al.J. Virol. 77:10414-10422(2003).
Blaise S.,et al.Proc. Natl. Acad. Sci. U.S.A. 100:13013-13018(2003).
Wang-Johanning F.,et al.Oncogene 22:1528-1535(2003).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.